Examkin

Tüm alıştırma soruları

4736 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 2361Soru →

A 79-year-old woman with vascular dementia is hospitalized for the management of acute pyelonephritis. On the second day of her admission, the cross-covering physician evaluates the patient after she is found on the floor of her room. Radiographs confirm a new right femoral neck fracture. A preliminary review of the electronic health record reveals that her high fall risk was documented upon admission. However, the bed alarm had been manually deactivated, and the daytime nursing staff did not mention the patient's escalating confusion or fall precautions during the evening shift transition. The patient is hemodynamically stabilized, and orthopedic surgery is consulted for operative repair. Which of the following is the most appropriate next step regarding the safety and quality improvement process for this event?

Cevabı ve açıklamayı göster

Cevap: Enter the adverse event into the institutional reporting system to facilitate a retrospective root cause analysis

Cevap

Enter the adverse event into the institutional reporting system to facilitate a retrospective root cause analysis
The correct action following an adverse event is to submit a formal incident report. This triggers a root cause analysis (RCA), a retrospective quality improvement process. RCA is designed to move beyond active human errors (e.g., turning off a bed alarm, failing to provide a complete handoff) and identify latent systemic vulnerabilities (e.g., poor alarm interface, high nurse-to-patient ratios, lack of standardized handoff tools) to prevent future occurrences.

Adım Adım Çözüm

1
Identify the nature of the event.
The patient experienced an in-hospital fall resulting in a femoral neck fracture due to a series of errors, which classifies as a serious adverse event.
Categorizing the event appropriately dictates the required administrative and safety response.
2
Determine the optimal administrative pathway for a severe adverse event that has already occurred.
The event must be formally documented in the institutional reporting system to initiate a Root Cause Analysis (RCA).
RCA is the standard retrospective tool used to investigate the systemic, latent causes of an adverse event, moving beyond individual blame.

Anahtar Kavram

In a robust patient safety culture, adverse events must be formally reported to initiate a Root Cause Analysis (RCA), a retrospective approach designed to identify and correct latent systemic errors rather than assign individual blame.
Soru 2362Soru →

A 30-year-old man undergoes an elective cholecystectomy. Postoperatively, the physician prescribes intravenous hydromorphone for pain control. The hospital's automated medication dispenser was recently restocked, but a pharmacy technician mistakenly placed vials of heparin into the hydromorphone compartment. Both vials have similarly colored caps and labels. The night-shift nurse, working a double shift due to staffing shortages, retrieves a vial from the hydromorphone compartment. The barcode scanner on the floor has been broken for two days, and the day-shift staff forgot to mention this during patient handoff. The nurse administers the medication without scanning it. The patient receives a large dose of heparin, subsequently develops a massive intra-abdominal hemorrhage, and requires emergency exploratory laparotomy.

Which of the following statements correctly classify the elements of this adverse event? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: The incorrect stocking of the automated dispenser and the unaddressed broken barcode scanner represent latent errors.; The direct administration of the incorrect medication to the patient by the bedside nurse represents an active error.

Cevap

The statements correctly identifying the stocking error and broken scanner as latent errors, and the administration of the drug as an active error, are correct.
The correct statements accurately identify the latent errors (the incorrect pharmacy stocking and the unaddressed broken barcode scanner) and the active error (the administration of the wrong medication). Latent errors are system-level vulnerabilities at the 'blunt end' of healthcare delivery, such as equipment failures, staffing shortages, or poor communication protocols. Active errors occur at the 'sharp end' of care and involve immediate acts by frontline personnel, such as a nurse administering the wrong medication without performing a manual verification when the scanner is broken. Both must align for an adverse event to reach the patient, as described by the Swiss Cheese Model.

Adım Adım Çözüm

1
Review the clinical scenario to identify the sequence of events leading to patient harm.
A pharmacy stocking error, a communication failure during handoff, a broken scanner, and a failure to verify the medication manually culminated in a severe hemorrhage.
Understanding the timeline and isolating each contributing factor is necessary to categorize the events accurately.
2
Differentiate between active and latent errors in the sequence.
System vulnerabilities (broken scanner, stocking error, poor handoff) are identified as latent errors, while the immediate incorrect administration by the frontline provider is an active error.
This distinction is the core of medical error classification according to the Swiss Cheese Model of accident causation.
3
Evaluate the remaining statements regarding system investigation tools, cognitive biases, and sentinel events.
FMEA is prospective (making it incorrect for investigating a past event), the bias is not the availability heuristic, and a handoff omission is a latent error rather than the sentinel event itself.
Eliminating plausible distractors confirms the final correct selections.

Anahtar Kavram

Classification of medical errors distinguishes between latent errors (underlying system-level vulnerabilities at the 'blunt end') and active errors (immediate, unsafe acts by frontline personnel at the 'sharp end').
Soru 2363Soru →

A 67-year-old woman is brought to the emergency department after suffering a massive intracranial hemorrhage. She is comatose, requires mechanical ventilation, and completely lacks medical decision-making capacity. The clinical team needs consent for an urgent neurosurgical intervention. A review of her electronic health record reveals she has no written advance directive and has never legally designated a healthcare proxy. Several individuals arrive at the hospital, each expressing a desire to direct her medical care. According to the standard statutory surrogate hierarchy, arrange the following individuals in the correct order of legal priority to act as the primary surrogate decision-maker, from highest priority (first) to lowest priority (last).

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct priority order is: husband (highest priority), followed sequentially by the adult daughter, mother, brother, and finally the close friend (lowest priority).
The standard legal statutory hierarchy for surrogate decision-making prioritizes family members based on presumed closeness and knowledge of the patient's values. The broad legal consensus for priority is: 1) Spouse or domestic partner, 2) Adult children, 3) Parents, 4) Adult siblings, and 5) Other relatives or close friends. Therefore, the husband has primary decision-making authority, followed sequentially by the daughter, mother, brother, and friend.

Adım Adım Çözüm

1
Assess the patient's capacity and check for appointed proxies.
The patient lacks capacity and has no legally designated healthcare proxy or advance directive.
A designated proxy (Durable Power of Attorney for Healthcare) or living will would explicitly supersede the default statutory hierarchy.
2
Apply the standard state statutory surrogate hierarchy to the available individuals.
Identify the exact relationship of each individual to the patient to determine their legal rank.
When no proxy is formally appointed, state laws dictate a specific order of individuals authorized to make medical decisions based on presumed knowledge of the patient's wishes.
3
Sequence the individuals from highest to lowest legal priority.
The order is Spouse > Adult Child > Parent > Adult Sibling > Close Friend.
This sequence reflects the ethical and legal consensus, assigning priority to those traditionally considered closest to the patient.

Anahtar Kavram

In the absence of a designated healthcare proxy or an applicable advance directive, medical decisions for an incapacitated patient are made by a surrogate determined by a state-specific statutory hierarchy. The standard order is: spouse, adult children, parents, adult siblings, and finally other relatives or close friends.
Soru 2364Soru →

A surgical technologist is assisting during an open exploratory laparotomy. Before the initial incision is made, the technologist observes the attending surgeon accidentally contaminate their sterile sleeve by brushing against an unsterile equipment monitor. The surgeon appears unaware of the breach and asks the technologist to hand them the scalpel. According to high-reliability organization principles and standardized conflict resolution frameworks, arrange the following actions the technologist should take in the correct chronological order to address this safety concern, assuming the surgeon is dismissive or resistant at each step.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first directly notify the surgeon, then use standardized assertive language if ignored, followed by escalating to the charge nurse, then to the medical director if needed, and finally filing an incident report after the case.
The correct sequence follows established high-reliability organization principles, specifically the Two-Challenge Rule and the formal chain of command. When a safety breach is observed, the first step is always direct, professional communication. If dismissed, the second step is a firmer assertion using standardized safety language (e.g., CUS: Concerned, Uncomfortable, Safety). If the individual still does not comply, the team member must 'stop the line' and escalate to immediate unit leadership, followed by departmental medical leadership if necessary. Only after the immediate clinical threat is resolved should a formal safety event report be filed.

Adım Adım Çözüm

1
Issue the first challenge.
The surgeon is made aware of the potential error directly and professionally.
Most medical errors are unintentional; a direct, non-confrontational alert usually resolves the issue immediately without needing escalation.
2
Issue the second challenge using standardized safety language.
The surgeon is clearly notified that this is a recognized safety issue, not just a casual observation.
If the first alert is dismissed, the Two-Challenge Rule requires a firmer restatement using keywords (like 'Concerned' or 'Safety') to trigger a mandatory pause.
3
Escalate to immediate unit leadership (Charge Nurse).
The local chain of command is activated to mediate the dispute and prevent patient harm.
When peer-to-peer resolution fails, immediate supervisors must intervene before the unsafe act (making the incision) occurs.
4
Escalate to departmental medical leadership.
The Chief of Surgery or Medical Director provides definitive authority to override the unsafe behavior.
If the attending physician refuses to comply with unit leadership, administrative medical authority is required to enforce safety standards.
5
File an institutional safety report.
The event is officially documented for the hospital's quality improvement committee.
Retrospective reporting ensures systemic issues are reviewed, but it must only occur after the immediate threat to the patient has been mitigated.

Anahtar Kavram

Standardized escalation of patient safety concerns using the Two-Challenge Rule and Chain of Command.
Soru 2365Soru →

Researchers at an academic medical center investigate the use of a novel microbiome restorative therapy to prevent recurrent *Clostridioides difficile* infection (CDI). The study enrolls adults who have recently completed standard antibiotic therapy for a first episode of CDI. Participants are randomly assigned in a 1:1 ratio to receive either the novel therapy or a visually matched placebo.

Over a 6-month follow-up period, the following data are recorded:

GroupTotal PatientsRecurrent CDI Events
Placebo40080
Novel therapy40032

Based on the study results, what is the number needed to treat (NNT) to prevent one additional episode of recurrent CDI? (Provide your answer as a whole number, applying standard epidemiological rounding principles).

Cevabı ve açıklamayı göster

Cevap: 9

Cevap

9
To find the number needed to treat (NNT), first calculate the absolute risk reduction (ARR). The risk of recurrent CDI in the placebo group (CER) is 80/400=0.2080/400 = 0.20. The risk in the treatment group (EER) is 32/400=0.0832/400 = 0.08. The ARR is the difference between these two rates: 0.20−0.08=0.120.20 - 0.08 = 0.12. The NNT is the reciprocal of the ARR: 1/0.12=8.331 / 0.12 = 8.33. In biostatistics, the NNT must always be rounded up to the next whole number (ceiling function) to provide a conservative estimate. Therefore, 8.338.33 rounds up to 99.

Adım Adım Çözüm

1
Calculate the Control Event Rate (CER).
CER = 80/400=0.2080 / 400 = 0.20 (20%20\%).
This establishes the baseline risk of the outcome (recurrent CDI) without the new intervention.
2
Calculate the Experimental Event Rate (EER).
EER = 32/400=0.0832 / 400 = 0.08 (8%8\%).
This establishes the risk of the outcome when using the novel therapy.
3
Calculate the Absolute Risk Reduction (ARR).
ARR = CER - EER = 0.20−0.08=0.120.20 - 0.08 = 0.12 (12%12\%).
ARR represents the actual difference in risk between the two groups, showing how much the intervention reduces the absolute risk of the event.
4
Calculate the Number Needed to Treat (NNT).
NNT = 1/ARR=1/0.12=8.331 / \text{ARR} = 1 / 0.12 = 8.33.
NNT is the reciprocal of the Absolute Risk Reduction. It indicates the theoretical number of patients that need to be treated to prevent one bad outcome.
5
Apply conservative rounding rules for NNT.
Round 8.338.33 up to 99.
Because treating 88 patients would only prevent 8×0.12=0.968 \times 0.12 = 0.96 events (less than one full event), you must treat the 9th9^{\text{th}} patient to guarantee the prevention of at least one event. NNT is always rounded up to the nearest whole number (ceiling function) to avoid overstating clinical benefit.

Anahtar Kavram

Number Needed to Treat (NNT) calculation and conservative rounding principles
Soru 2366Soru →

A hospital's evidence-based medicine committee is reviewing a series of novel diagnostic assays for infectious diseases. To standardize interpretation across the health system, they are categorizing tests based on their likelihood ratios (LR). Match each likelihood ratio profile with its corresponding qualitative impact on the post-test probability of disease.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A diagnostic test yielding a Positive Likelihood Ratio (LR+) > 10
A diagnostic test yielding a Positive Likelihood Ratio (LR+) between 1.1 and 2.0
A diagnostic test yielding a Negative Likelihood Ratio (LR-) < 0.1
A diagnostic test yielding a Negative Likelihood Ratio (LR-) between 0.5 and 0.9

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matching pairs likelihood ratios with their established qualitative effects on post-test probability: LR+ > 10 produces large, conclusive increases; LR+ 1.1-2.0 produces negligible increases; LR- < 0.1 produces large, conclusive decreases; and LR- 0.5-0.9 produces negligible decreases.
Likelihood ratios (LRs) are critical for evidence-based diagnosis because, unlike predictive values, they are independent of the underlying disease prevalence in the tested population. They allow clinicians to estimate post-test probability using Fagan's nomogram or approximation heuristics. By established standards, an LR+ > 10 increases probability by roughly 45%, providing strong, often conclusive evidence to rule in a diagnosis. Conversely, an LR- < 0.1 decreases probability by roughly 45%, providing strong evidence to rule out a diagnosis. Likelihood ratios approaching 1 (such as LR+ 1.1-2.0 or LR- 0.5-0.9) indicate that the test result is almost equally likely to occur in patients with and without the disease, thereby providing minimal to no clinically meaningful shift in probability.

Adım Adım Çözüm

1
Evaluate the clinical significance of a Positive Likelihood Ratio (LR+) greater than 10.
Matches with a large and conclusive increase in post-test probability.
LR+ indicates how much more likely a positive test is in diseased versus non-diseased individuals. Values > 10 are considered excellent benchmarks for confirming disease.
2
Evaluate the clinical significance of a Negative Likelihood Ratio (LR-) less than 0.1.
Matches with a large and conclusive decrease in post-test probability.
LR- indicates how likely a negative test is in diseased versus non-diseased individuals. Values < 0.1 are considered excellent benchmarks for ruling out disease.
3
Evaluate likelihood ratios close to 1 (e.g., LR+ 1.1-2.0 and LR- 0.5-0.9).
Match with small, rarely clinically meaningful shifts in post-test probability.
An LR of 1 means the test result occurs equally in diseased and healthy patients, offering zero diagnostic value. Values approaching 1 offer minimal utility and do not meaningfully alter clinical management.

Anahtar Kavram

Interpretation of Likelihood Ratios
Soru 2367Soru →

A 68-year-old man is evaluated by his primary care physician prior to hospital discharge. The patient was admitted three days ago for an acute ischemic stroke resulting in mild left-sided hemiparesis. He is now medically stable and meets all criteria for discharge to home. The multidisciplinary team recommends intensive outpatient physical therapy to maximize his functional recovery. The patient receives his health coverage through Medicare. The physician's spouse is the sole proprietor of a local outpatient physical therapy and rehabilitation center. The physician knows the center provides excellent care and is conveniently located near the patient's home. Which of the following is the most appropriate action regarding the patient's physical therapy referral?

Cevabı ve açıklamayı göster

Cevap: Provide the patient with a list of other physical therapy facilities and do not refer him to the spouse's clinic.

Cevap

Provide the patient with a list of other physical therapy facilities and do not refer him to the spouse's clinic.
The correct action is to refrain from referring the patient to the spouse's clinic and instead provide a list of alternative physical therapy centers. The Ethics in Patient Referrals Act, commonly known as the Stark Law, strictly prohibits a physician from referring Medicare or Medicaid patients for 'designated health services' (DHS) to an entity with which the physician or an immediate family member (e.g., a spouse) has a financial relationship. Physical therapy is explicitly classified as a DHS. Because this is a strict liability statute, providing a formal disclosure, obtaining informed consent, or relying on the high quality of the clinic does not exempt the physician from the prohibition.

Adım Adım Çözüm

1
Identify the legal framework governing the scenario.
The scenario involves a physician considering referring a Medicare patient for physical therapy to a facility owned by an immediate family member.
Recognizing the components (Medicare, designated health service, family ownership) triggers the application of the Stark Law (Ethics in Patient Referrals Act).
2
Apply the provisions of the Stark Law to the proposed referral.
The Stark Law strictly prohibits physicians from referring Medicare or Medicaid patients for designated health services (which includes physical therapy) to entities with which the physician or an immediate family member has a financial relationship.
This is a strict liability statute, meaning that good intentions, patient consent, or financial disclosure do not provide exceptions to the rule.
3
Determine the most appropriate physician action based on the legal restrictions.
The physician must completely refrain from referring the patient to the spouse's clinic and should instead provide alternatives.
To ensure the patient receives the necessary post-stroke rehabilitation without violating federal law, the physician must offer alternative facilities in the community.

Anahtar Kavram

Under the Stark Law, physicians are prohibited from referring Medicare or Medicaid patients for designated health services (including physical therapy) to entities in which the physician or an immediate family member holds a financial interest, regardless of disclosure.
Soru 2368Soru →

A 59-year-old woman is evaluated in the hospital for intractable nausea, vomiting, and diffuse abdominal pain. She has a history of stage IV ovarian cancer with extensive peritoneal carcinomatosis that is no longer responsive to chemotherapy. Three days ago, her oncologist discussed her prognosis, and the patient expressed a clear desire to focus exclusively on comfort care and avoid further invasive procedures. Over the past 24 hours, she has been unable to tolerate any oral intake, and her last bowel movement was four days ago. She is awake, alert, and fully oriented. She reiterates her goals of care and explicitly refuses any surgical evaluation. Her temperature is 37.1°C (98.8°F), blood pressure is 105/65 mm Hg, pulse is 110/min, and respirations are 18/min. Physical examination reveals a markedly distended, tympanic abdomen with high-pitched, tinkling bowel sounds. There is diffuse mild tenderness but no rebound or guarding. Plain radiography of the abdomen shows multiple dilated loops of small bowel with air-fluid levels and a paucity of gas in the colon. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Subcutaneous octreotide

Cevap

The most appropriate next step in management is the administration of subcutaneous octreotide.
The correct answer is subcutaneous octreotide because it effectively reduces gastrointestinal secretions, pancreatic secretions, and splanchnic blood flow. In a patient with an inoperable malignant bowel obstruction who desires comfort care, octreotide significantly decreases intraluminal volume and pressure, thereby alleviating intractable vomiting and severe abdominal distension without the need for surgical intervention.

Adım Adım Çözüm

1
Identify the clinical syndrome based on the presentation and imaging.
The patient has intractable vomiting, a distended tympanic abdomen, obstipation, and air-fluid levels on radiography, which are classic signs of a malignant bowel obstruction (MBO).
Recognizing the underlying pathology is necessary to select targeted pharmacologic therapies.
2
Determine the appropriate goals of care based on the patient's preferences.
The patient has decision-making capacity and has explicitly requested a comfort-focused approach, refusing further invasive or surgical procedures.
Patient autonomy dictates that management must align with her expressed desire to avoid invasive interventions.
3
Select the most appropriate medical intervention to alleviate the specific symptoms of MBO.
Subcutaneous octreotide is chosen to manage the obstruction medically.
Octreotide, a somatostatin analog, decreases gastrointestinal secretions and motility, which effectively reduces intraluminal pressure, abdominal distension, and vomiting in inoperable MBO.

Anahtar Kavram

The medical management of malignant bowel obstruction in palliative care focuses on symptom control using anti-secretory agents (such as octreotide), antiemetics, and analgesics, while strictly honoring the patient's goals of care and avoiding invasive procedures if comfort is the primary objective.
Soru 2369Soru →

A local health department is conducting an observational study to investigate the association between residential proximity to a major highway and the incidence of childhood asthma. The investigators identify household income level as a significant potential confounder in this relationship. Which of the following strategies are appropriate to control for the confounding effect of household income in this study? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Matching participants in the exposed and unexposed groups based on their household income.; Including household income as a covariate in a multivariable regression analysis.

Cevap

The appropriate strategies are matching participants based on their household income and including household income as a covariate in a multivariable regression analysis.
To control for confounding in an observational study, investigators can use strategies during the design phase or the analysis phase. Matching participants based on the confounding variable (household income) during enrollment ensures that the confounder is equally distributed between the exposed and unexposed groups. During the analysis phase, including the confounder as a covariate in a multivariable regression model allows the statistical software to mathematically adjust for its effect, isolating the true relationship between the primary exposure and the outcome.

Adım Adım Çözüm

1
Identify the study type and the statistical problem.
The study is observational, and there is a need to control for a known confounder (household income).
Understanding the study design dictates which methodological and statistical techniques can be used for confounder control.
2
Evaluate design-phase methods for controlling confounding.
Matching is a valid design-phase method because it forces the confounder to be equally distributed between the exposed and unexposed groups.
Matching directly addresses the imbalance before data collection even begins.
3
Evaluate analysis-phase methods for controlling confounding.
Multivariable regression is a valid analysis-phase method because it mathematically adjusts for the confounder's impact.
Regression isolates the independent effect of the primary exposure by holding the confounding variable constant in the statistical model.

Anahtar Kavram

Confounding can be effectively controlled during the design phase (via matching, restriction, or randomization) or the analysis phase (via stratification or multivariable regression).
Soru 2370Soru →

A 32-year-old junior oncologist is working in a busy outpatient infusion center. While reviewing orders, the physician notes that a senior partner has just prescribed a chemotherapy dose that is three times the recommended limit for a patient currently waiting in the infusion suite. The junior physician immediately approaches the senior partner to discuss the discrepancy. The senior partner appears disoriented, cannot recall the patient's diagnosis, and asks where the hospital cafeteria is, despite having worked in this clinic for 15 years. Over the past three months, clinic staff have noted the senior partner having increasing memory lapses and deteriorating personal hygiene. Which of the following is the most appropriate next step by the junior physician?

Cevabı ve açıklamayı göster

Cevap: Cancel the erroneous chemotherapy order and notify the clinic's medical director regarding the colleague's suspected cognitive impairment

Cevap

Cancel the erroneous chemotherapy order and notify the clinic's medical director regarding the colleague's suspected cognitive impairment
Physicians have a strict ethical and legal obligation to report colleagues who are impaired due to substance use, psychiatric illness, or cognitive decline. When a physician encounters an impaired colleague, the absolute first priority is to protect patient safety. In this scenario, a potentially lethal chemotherapy dose has been ordered and the patient is actively waiting. The junior physician must immediately intervene to cancel the erroneous order. Once the patient is safe, the physician must report the impaired colleague to the appropriate institutional authority, such as the clinic's medical director, the chief of staff, or a physician health program. These bodies have the resources to properly evaluate the physician, mandate administrative leave if necessary, and ensure ongoing patient safety.

Adım Adım Çözüm

1
Identify the immediate clinical threat.
A dangerous chemotherapy order has been placed for a waiting patient.
The primary duty of a physician is to do no harm; acute threats to patients must be addressed before administrative tasks.
2
Recognize the signs of physician impairment.
The senior partner is showing overt signs of progressive neurocognitive decline, such as memory lapses and severe disorientation.
Identifying the impairment dictates the appropriate ethical reporting pathway.
3
Determine the required ethical sequence of actions.
Intervene immediately to cancel the order, then report the physician to the institutional authority.
Patient safety is secured first, followed by institutional reporting (e.g., to the medical director) to initiate a formal health evaluation.

Anahtar Kavram

When dealing with an impaired physician, the absolute first priority is immediate patient safety (preventing harm), followed immediately by reporting the impairment to the appropriate institutional authority (e.g., medical director, chief of staff, or physician health program).
Soru 2371Soru →

A 52-year-old woman comes to the ambulatory care clinic for a follow-up visit. She has a history of unprovoked recurrent deep vein thrombosis and is currently on long-term anticoagulation therapy with warfarin. She expresses intense frustration with the required frequent international normalized ratio (INR) blood draws. She tells the physician, "I am done with this medication. I am stopping the warfarin today. I started taking high-dose garlic and ginseng supplements instead, which I read naturally thin the blood without needing constant lab tests. I am fully aware of the risks, and I have the legal competence to refuse any treatment I do not want." She is alert, oriented, and demonstrates a clear understanding of her condition and the potential consequences of stopping therapy. Which of the following is the most appropriate response by the physician?

Cevabı ve açıklamayı göster

Cevap: You have the capacity to make your own medical decisions, but I must warn you that these supplements are not a proven substitute and can unpredictably alter your bleeding risk.

Cevap

The correct answer acknowledges the patient's clinical capacity to refuse treatment while providing essential medical education about the risks and lack of proven efficacy of her proposed herbal supplements.
The correct response properly distinguishes between clinical capacity (determined by a physician) and legal competence (determined by a judge). Since the patient understands the risks, she has the capacity to refuse therapy. The physician correctly respects this autonomy while fulfilling the duty to warn her that garlic and ginseng can dangerously interact with hemostasis and are not viable substitutes for anticoagulation.

Adım Adım Çözüm

1
Assess the patient's ability to make healthcare decisions.
The patient demonstrates an understanding of her medical condition and the consequences of her choice, indicating she has clinical decision-making capacity.
A patient with clinical capacity has the ethical and legal right to refuse medical treatment, even if the physician disagrees with the choice.
2
Evaluate the patient's proposed alternative treatment (garlic and ginseng) for her condition.
These supplements are not standard-of-care for deep vein thrombosis and have known interactions that alter hemostasis.
Physicians must educate patients on the risks of unproven therapies and potential adverse effects to ensure informed decision-making.
3
Formulate the most appropriate patient counseling response.
The physician should validate her autonomy by confirming her capacity to choose, but strongly advise against the dangerous substitution.
This approach appropriately balances patient autonomy with the ethical principles of beneficence and nonmaleficence.

Anahtar Kavram

Patient counseling on autonomy, decision-making capacity versus legal competence, and the risks of herbal supplement interactions in anticoagulation therapy.
Tahmini Süre:1m 15s
Soru 2372Soru →

A public health department is investigating an increased incidence of chronic kidney disease of unknown etiology (CKDu) in a specific rural region. Investigators conduct a 10-year cohort study to evaluate the association between exposure to a specific agrochemical mixture and the development of CKDu. The study includes agricultural workers with documented daily exposure to the mixture and non-agricultural workers from the same region without exposure. The findings are summarized in the following table:

Exposure StatusCKDu DevelopedTotal Subjects
Exposed160800
Unexposed601,200

Based on these study results, what percentage of the CKDu cases among the exposed agricultural workers can be attributed to the agrochemical exposure?

Cevabı ve açıklamayı göster

Cevap: 75%

Cevap

75%
The correct answer is 75%75\%. The question asks for the percentage of disease cases in the exposed group that can be attributed to the exposure, which is the Attributable Risk Percent (ARP), also known as the etiologic fraction. ARP is calculated using the formula: ARP=Incidence in exposed−Incidence in unexposedIncidence in exposedARP = \frac{\text{Incidence in exposed} - \text{Incidence in unexposed}}{\text{Incidence in exposed}}. First, find the incidence in the exposed group (160/800=0.20160 / 800 = 0.20 or 20%20\%). Next, find the incidence in the unexposed group (60/1,200=0.0560 / 1,200 = 0.05 or 5%5\%). Finally, apply the formula: 0.20−0.050.20=0.150.20=0.75\frac{0.20 - 0.05}{0.20} = \frac{0.15}{0.20} = 0.75, which is 75%75\%. This means 75%75\% of the CKDu cases among these agricultural workers are due to the agrochemical exposure.

Adım Adım Çözüm

1
Calculate the incidence of CKDu in the exposed group (IeI_e).
Ie=160800=0.20I_e = \frac{160}{800} = 0.20 (20%20\%).
This establishes the total disease risk among those exposed to the agrochemicals.
2
Calculate the incidence of CKDu in the unexposed group (IuI_u).
Iu=601,200=0.05I_u = \frac{60}{1,200} = 0.05 (5%5\%).
This establishes the baseline risk of the disease in the population without the exposure.
3
Calculate the Attributable Risk Percent (ARP).
ARP=Ie−IuIe=0.20−0.050.20=0.150.20=0.75ARP = \frac{I_e - I_u}{I_e} = \frac{0.20 - 0.05}{0.20} = \frac{0.15}{0.20} = 0.75 (75%75\%).
ARP determines the proportion of the disease in the exposed group that is directly linked to the exposure, accounting for the baseline risk.

Anahtar Kavram

Attributable Risk Percent (ARP)
Soru 2373Soru →

A 42-year-old man is hospitalized for the treatment of acute myeloid leukemia. He develops a temperature of 39.1°C (102.4°F) and has an absolute neutrophil count of 150/mm³. The covering night-shift hospitalist orders empirical intravenous vancomycin and cefepime. The clinical pharmacist reviews the patient's electronic health record and notes a documented history of severe, IgE-mediated anaphylaxis to all cephalosporins. The pharmacist pages the hospitalist to recommend an alternative antipseudomonal agent. The hospitalist, who is currently managing a cardiac arrest on another floor, answers the call and states, 'I do not have time to review the allergy history right now. The febrile neutropenia protocol requires this regimen, so please verify the order immediately,' and abruptly hangs up. Which of the following is the most appropriate next step for the pharmacist?

Cevabı ve açıklamayı göster

Cevap: Withhold the cephalosporin and immediately escalate the safety concern to the supervising attending physician.

Cevap

The pharmacist should withhold the contraindicated medication and activate the chain of command by escalating the concern to the supervising attending physician.
The correct action is to withhold the medication and escalate the concern. In high-reliability healthcare organizations, any team member has the authority and professional obligation to 'stop the line' if a critical patient safety threat is identified. Because the prescribing physician is dismissive and unavailable for further discussion (due to managing a separate clinical emergency), the pharmacist cannot safely resolve the conflict directly with the prescriber at this moment. The most appropriate action to prevent patient harm, while ensuring the patient eventually receives the correct alternative treatment, is to activate the formal chain of command by contacting the supervising attending physician.

Adım Adım Çözüm

1
Identify the critical safety threat.
The prescribed medication (cefepime) is absolutely contraindicated due to a history of IgE-mediated anaphylaxis.
Administering the medication would cause immediate, severe harm to the patient.
2
Recognize the communication breakdown.
The prescribing physician is cognitively overloaded with an emergency and is unable/unwilling to process the safety warning.
Standard peer-to-peer conflict resolution (like the Two-Challenge Rule) cannot be completed effectively in this immediate context.
3
Apply the appropriate systemic safety framework.
The pharmacist must 'stop the line' and utilize the chain of command to escalate the issue to the attending physician.
Patient safety supersedes hierarchy; when a direct provider cannot correct a critical error, the concern must be escalated upward until resolved.

Anahtar Kavram

Chain of Command and Escalation in Patient Safety
Soru 2374Soru →

A 62-year-old man presents to the emergency department with sudden-onset left-sided weakness and slurred speech. He has a history of hypertension and type 2 diabetes. A new point-of-care biomarker assay is being evaluated in the emergency department to aid in the diagnosis of acute ischemic stroke. The prevalence (pre-test probability) of acute ischemic stroke in patients presenting to this department with similar symptoms is estimated to be 30%30\%. The biomarker assay has a reported sensitivity of 90%90\% and a specificity of 85%85\%. The patient undergoes the assay, and the result is positive.

Based on these parameters, what is the probability (in percentage) that this patient actually has an acute ischemic stroke?

Cevabı ve açıklamayı göster

Cevap: 72

Cevap

72
The correct answer is 7272. The positive predictive value (PPV) calculates the probability that a patient has the disease given a positive test result. This value heavily depends on the sensitivity, specificity, and prevalence (pre-test probability) of the disease. Using a 2×22 \times 2 table for a hypothetical cohort of 10001000 patients: 300300 have the disease and 700700 do not. The test correctly identifies 270270 of the 300300 diseased patients (90%90\% sensitivity). It incorrectly identifies 105105 of the 700700 healthy patients (100%−85%100\% - 85\% specificity). The total number of positive tests is 270+105=375270 + 105 = 375. The PPV is the number of true positives divided by the total positives: 270375=72%\frac{270}{375} = 72\%.

Adım Adım Çözüm

1
Determine the disease and non-disease populations
Disease = 300, No Disease = 700
Using a hypothetical cohort of 1000 patients and a prevalence of 30% simplifies the calculation.
2
Calculate True Positives (TP)
TP = 270
Sensitivity is 90%, so 90% of the 300 patients with the disease will correctly test positive.
3
Calculate False Positives (FP)
FP = 105
Specificity is 85%, so 15% of the 700 patients without the disease will incorrectly test positive.
4
Calculate the Positive Predictive Value (PPV)
PPV = 72%
PPV is the proportion of true positives out of all positive tests: TP / (TP + FP) = 270 / 375 = 0.72.

Anahtar Kavram

Positive Predictive Value calculation using pre-test probability (prevalence), sensitivity, and specificity.
Soru 2375Soru →

A 68-year-old man presents to the clinic for a routine wellness examination. His past medical history is significant for type 2 diabetes mellitus, essential hypertension, and hyperlipidemia. His current prescribed medications include lisinopril, amlodipine, and atorvastatin. During the interview, the patient appears visibly anxious and states, "My neighbor just passed away from metastatic prostate cancer. I want to be absolutely sure I do not have it, so I need you to run that prostate blood test today. Also, to improve my heart health, I started drinking grapefruit juice every morning and taking an over-the-counter red yeast rice supplement." Which of the following is the most appropriate initial counseling response by the physician?

Cevabı ve açıklamayı göster

Cevap: I understand that your neighbor's passing has made you worried about prostate cancer, and we will definitely discuss the benefits and risks of testing today. However, I first need to urgently advise you to stop the grapefruit juice and red yeast rice, as they can interact dangerously with your cholesterol medication.

Cevap

The correct answer is the statement that validates the patient's anxiety regarding prostate cancer, commits to shared decision-making, and urgently prioritizes counseling against the dangerous interaction between atorvastatin, grapefruit juice, and red yeast rice.
The correct response effectively manages multiple clinical priorities simultaneously. It utilizes core communication skills by validating the patient's anxiety and setting an agenda to address his primary concern (the PSA test via shared decision-making). Crucially, it then pivots to immediately educate the patient on a critical safety issue: the severe pharmacokinetic interaction between his prescribed atorvastatin (a CYP3A4 substrate), grapefruit juice (a CYP3A4 inhibitor), and red yeast rice (which contains naturally occurring lovastatin).

Adım Adım Çözüm

1
Analyze the patient's statements to identify all clinical and psychological concerns.
The patient is expressing grief/anxiety about prostate cancer demanding a PSA test, and has newly initiated grapefruit juice and red yeast rice.
Effective patient counseling requires addressing both the patient's stated agenda and any silent medical risks they introduce.
2
Evaluate the safety of the patient's newly initiated health behaviors.
Grapefruit juice is a potent inhibitor of CYP3A4, which metabolizes atorvastatin. Red yeast rice contains monacolin K, structurally identical to lovastatin. Taking all three together causes severe statin toxicity (myopathy/rhabdomyolysis).
Life-threatening pharmacological interactions must take precedence in clinical counseling to ensure patient safety.
3
Evaluate the request for the PSA test against current preventive guidelines.
For men aged 55 to 69, the USPSTF recommends that the decision to undergo periodic PSA-based screening be an individual one (shared decision-making), not a mandatory or universally recommended test.
The physician must accurately represent guidelines without dismissing the patient's fears.
4
Formulate the optimal communication strategy.
The physician must immediately validate the emotional concern, agree to discuss the PSA test using shared decision-making, but firmly and clearly counsel the patient to stop the dangerous supplements.
This approach maintains the physician-patient relationship while addressing immediate physiological threats.

Anahtar Kavram

In patient counseling, physicians must balance empathetic validation of patient concerns with immediate, clear education regarding life-threatening pharmacological interactions.
Soru 2376Soru →

An integrated health system initiates a pragmatic randomized controlled trial to assess a novel electronic health record (EHR) alert designed to prevent acute kidney injury (AKI) in patients receiving nephrotoxic medications. The investigators calculate a required sample size of 4,500 patient encounters to achieve 90% statistical power (β=0.10\beta = 0.10) to detect a 25% relative reduction in AKI incidence, utilizing a two-tailed α\alpha of 0.05. This calculation is based on historical data showing a baseline AKI incidence of 12% in this population.

Six months into the trial, a blinded interim analysis reveals that the overall pooled incidence of AKI across both the intervention and control arms is only 6%. Investigation reveals this is likely due to a hospital-wide intravenous hydration protocol implemented independently just before the trial began. The investigators determine that a 25% relative reduction in AKI remains the minimum clinically important difference they wish to detect.

If the investigators proceed without altering the planned sample size of 4,500 encounters, which of the following describes the most accurate statistical consequence of this unexpected drop in baseline incidence?

Cevabı ve açıklamayı göster

Cevap: The statistical power to detect the 25% relative reduction will decrease, increasing the probability of a Type II error.

Cevap

The statistical power to detect the 25% relative reduction will decrease, increasing the probability of a Type II error.
The correct answer identifies that a decrease in the baseline incidence rate significantly reduces the total number of expected outcome events in the trial. Statistical power is highly dependent on the number of events. When the baseline rate drops from 12% to 6%, a 25% relative risk reduction corresponds to an absolute risk reduction of only 1.5% (down from the originally planned 3.0%). Detecting a smaller absolute difference with fewer total events requires a much larger sample size. Because the investigators are keeping the sample size fixed at 4,500 encounters, the study becomes severely underpowered for the new 1.5% absolute difference. This loss of statistical power directly increases the risk of a Type II error (failing to detect a true difference).

Adım Adım Çözüm

1
Identify the primary change in the study's parameters.
The baseline incidence of the outcome (AKI) unexpectedly dropped from 12% to 6%.
Recognizing the altered variable is necessary to determine its downstream effects on the trial's statistical calculations.
2
Calculate the impact of this change on the expected absolute risk reduction.
Originally: 25% relative reduction of a 12% baseline = 3% absolute reduction. Now: 25% relative reduction of a 6% baseline = 1.5% absolute reduction.
Statistical power depends on the absolute difference between groups, not just the relative difference.
3
Relate the absolute risk reduction and overall event count to statistical power.
A smaller absolute difference (1.5%) and a lower total number of expected events require a significantly larger sample size to detect with 90% power.
In event-driven trials, power is primarily driven by the total number of observed outcomes.
4
Determine the consequence of keeping the sample size fixed at the original number.
Since the sample size remains 4,500, the study lacks the required data points to detect the 1.5% absolute difference. Power decreases, meaning β\beta (Type II error rate) increases.
Power and Type II error are inversely related (Power = 1−β1 - \beta).

Anahtar Kavram

In clinical trials with binary outcomes, statistical power depends heavily on the baseline event rate. If the baseline event rate is lower than expected, the absolute number of events decreases, which significantly reduces the study's power and increases the risk of a Type II error unless the sample size is proportionally increased.
Tahmini Süre:3m 0s
Soru 2377Soru →

A hospital biostatistics committee is reviewing the diagnostic protocols for a novel continuous quantitative serum biomarker used to detect severe sepsis. Depending on the primary clinical objective and the target population, the decision thresholds (cutoffs) and pretest probabilities may vary. Match each proposed clinical or protocol adjustment on the left with its theoretical impact on the test's statistical performance metrics on the right.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Increasing the numeric cutoff threshold for a positive test to prioritize the avoidance of unnecessary broad-spectrum antibiotic administration.
Decreasing the numeric cutoff threshold for a positive test to minimize the risk of missing early-stage septic shock.
Implementing the assay exclusively in the intensive care unit, where the baseline incidence of severe sepsis is significantly elevated.
Expanding the biomarker screening to all walk-in urgent care patients, where the baseline incidence of severe sepsis is exceedingly rare.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Adjustments to cutoff thresholds alter intrinsic characteristics (Type I/II error rates) and predictive values, while changes to population prevalence alter only predictive values (FDR/FOR) without affecting intrinsic characteristics or likelihood ratios.
Matching the clinical adjustments to their statistical outcomes relies on separating intrinsic test property alterations from prevalence-driven predictive value shifts. Changing the cutoff threshold directly trades Type I errors for Type II errors (altering Sensitivity, Specificity, and Likelihood Ratios), while changing the tested population alters only the baseline prevalence, shifting the False Discovery Rate (1 - PPV) and False Omission Rate (1 - NPV) without affecting the Likelihood Ratios.

Adım Adım Çözüm

1
Translate statistical terminology into standard diagnostic metrics.
Type I error rate = 1 - Specificity (False Positive Rate). Type II error rate = 1 - Sensitivity (False Negative Rate). False Discovery Rate (FDR) = 1 - PPV. False Omission Rate (FOR) = 1 - NPV.
Accurate terminology translation is essential to evaluate the provided outcomes.
2
Evaluate the effect of altering decision thresholds (cutoffs).
Raising the cutoff increases Specificity (lowers Type I error) and decreases Sensitivity (raises Type II error). Lowering the cutoff increases Sensitivity (lowers Type II error) and decreases Specificity (raises Type I error).
Cutoff thresholds determine the trade-off between false positives and false negatives along the overlapping healthy and diseased population distributions.
3
Evaluate the effect of altering disease prevalence.
Higher prevalence increases PPV (lowers FDR) and decreases NPV (raises FOR). Lower prevalence decreases PPV (raises FDR) and increases NPV (lowers FOR).
Pretest probability directly influences post-test predictive values based on Bayes' theorem.
4
Differentiate the effect on Likelihood Ratios (LRs).
LRs are calculated purely from Sensitivity and Specificity. Therefore, changing prevalence has no effect on LRs, whereas changing cutoff thresholds alters LRs.
Identifying which interventions leave LRs unchanged isolates the scenarios involving solely population shifts (prevalence changes).

Anahtar Kavram

The relationship between diagnostic thresholds, disease prevalence, and derivative statistical metrics including Type I/II errors, false discovery/omission rates, and likelihood ratios.

Alternatif Yöntem

Drawing out a 2x2 contingency table for each scenario and placing arrows indicating which cells increase or decrease can visually confirm these abstract mathematical relationships.
Tahmini Süre:2m 30s
Soru 2378Soru →

A 62-year-old man is admitted to the orthopedic unit following a total hip arthroplasty. On postoperative day 2, he develops sudden-onset chest pain, tachycardia, and dyspnea. The cross-covering physician evaluates the patient and suspects an acute pulmonary embolism. The physician orders a therapeutic dose of intravenous enoxaparin. The patient's electronic medical record contains a clearly documented severe allergy to heparin, specifically noting a history of heparin-induced thrombocytopenia. When the physician places the order, a computerized physician order entry (CPOE) alert is generated. However, the physician overrides the alert, assuming it is a generic, low-priority warning, as the system frequently flags non-critical drug interactions. The nurse administers the medication. Over the next 24 hours, the patient develops severe thrombocytopenia and a new deep vein thrombosis. The patient is transferred to the intensive care unit, stabilized with a non-heparin anticoagulant, and the error is disclosed to the patient and his family. Which of the following is the most appropriate next step in the institutional review of this adverse event?

Cevabı ve açıklamayı göster

Cevap: Convene a multidisciplinary committee to perform a root cause analysis of the system vulnerabilities

Cevap

Convene a multidisciplinary committee to perform a root cause analysis of the system vulnerabilities
The correct answer addresses the need for a Root Cause Analysis (RCA). The scenario describes a severe adverse event resulting from a combination of human error and systemic issues (alert fatigue in the CPOE system). The standard protocol for investigating a sentinel or severe adverse event that has already occurred is to perform a retrospective, multidisciplinary RCA. RCA focuses on identifying latent systemic errors to implement structural changes and prevent recurrence. This approach aligns perfectly with a 'Just Culture' of patient safety, which prioritizes system improvement over individual punishment.

Adım Adım Çözüm

1
Identify the nature of the safety incident.
A severe adverse event occurred (administration of a contraindicated medication causing harm) due to an overridden CPOE warning and alert fatigue.
Categorizing the event determines the appropriate administrative and safety response required by the institution.
2
Determine the appropriate institutional response tool for an event that has already caused harm.
A retrospective investigation is required.
Since the adverse event has already occurred, prospective tools are inappropriate. A retrospective analysis is needed to understand the sequence of events.
3
Apply the principles of a Just Culture to select the specific investigative method.
A Root Cause Analysis (RCA) is selected to investigate system flaws (like alert fatigue) rather than punishing the individual physician.
Just Culture emphasizes that most errors are caused by systemic vulnerabilities. Blaming the individual leads to underreporting and fails to prevent future errors.

Anahtar Kavram

Root Cause Analysis (RCA) is a retrospective, multidisciplinary process used to investigate adverse events by identifying underlying systemic vulnerabilities (e.g., alert fatigue) rather than assigning individual blame.
Soru 2379Soru →

Review the following four distinct ambulatory patient presentations. For each clinical scenario, select the single most appropriate, guideline-concordant preventive intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

28-year-old pregnant patient at 34 weeks gestation. During her prior pregnancy 18 months ago, she received both the Tdap and maternal respiratory syncytial virus (RSV) vaccines.
42-year-old premenopausal woman with a history of surgically excised lobular carcinoma in situ (LCIS). She had a negative screening mammogram one month ago and desires maximal breast cancer risk reduction.
68-year-old man who quit smoking exactly 14 years ago after a 45 pack-year history. His most recent low-dose computed tomography (LDCT) of the chest was 3 years ago and was negative.
38-year-old asymptomatic man presenting for a new patient evaluation. His mother was diagnosed with sporadic colorectal adenocarcinoma at age 46.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matching aligns each complex patient presentation with its precise, guideline-specific preventive care step, highlighting maternal vaccine limits, chemoprevention in LCIS, LDCT cessation timing, and aggressive CRC screening in early-onset family history.
Each clinical scenario requires precise application of current USPSTF and ACIP guidelines. The pregnant patient requires only Tdap because the maternal RSV vaccine is not repeated in subsequent pregnancies. The premenopausal woman with LCIS benefits from tamoxifen for breast cancer chemoprevention. The 68-year-old former smoker requires his annual LDCT now, but will age out of the screening window next year when he reaches 15 years post-cessation. The 38-year-old man requires immediate colonoscopy (10 years prior to his mother's diagnosis at 46) with an accelerated 5-year follow-up interval.

Adım Adım Çözüm

1
Evaluate the pregnant patient's prior vaccine history.
Patient had the RSV vaccine in a prior pregnancy.
ACIP states RSV is given once per lifetime during pregnancy, whereas Tdap is required during every pregnancy regardless of prior intervals.
2
Assess the premenopausal patient with LCIS.
Patient is a candidate for chemoprevention with tamoxifen.
LCIS is a high-risk marker; tamoxifen reduces invasive disease risk and is uniquely approved for premenopausal women, unlike raloxifene.
3
Calculate the former smoker's exact quit duration.
Patient quit 14 years ago.
LDCT is required annually until exactly 15 years of smoking cessation have elapsed. He needs a scan this year and will cease screening next year.
4
Determine the colon cancer screening threshold for the asymptomatic 38-year-old.
Initiate screening immediately with 5-year intervals.
A first-degree relative diagnosed at age 46 dictates that screening starts at age 36 (10 years prior) and recurs every 5 years, bypassing average-risk age 45 guidelines.

Anahtar Kavram

Nuanced application of preventive care guidelines, including lifetime maternal vaccine limits, breast cancer chemoprevention agents by menopausal status, lung cancer screening cessation criteria, and high-risk colorectal cancer screening intervals.
Soru 2380Soru →

A large regional healthcare system is evaluating a newly developed stool DNA panel for colorectal cancer screening. In clinical validation trials conducted at a specialized high-risk genetics clinic, where the prevalence of colorectal cancer is 15%15\%, the test demonstrated a sensitivity of 92%92\% and a specificity of 95%95\%. The healthcare system's administration now plans to deploy this stool DNA panel as a primary screening tool for average-risk adults in the general community, where the prevalence of colorectal cancer is approximately 0.6%0.6\%. Assuming the intrinsic test characteristics remain constant, which of the following is the most accurate statement regarding the community-wide deployment of this test?

Cevabı ve açıklamayı göster

Cevap: The majority of patients who test positive in the general community will not actually have the disease

Cevap

The majority of patients who test positive in the general community will not actually have the disease.
Positive predictive value (PPV) is highly dependent on disease prevalence. When a test is moved from a high-prevalence setting (15%15\%) to a low-prevalence setting (0.6%0.6\%), the PPV drops significantly. In the general community, for every 1,0001,000 patients screened, only about 66 actually have the disease, yielding approximately 55 or 66 true positive results (6×0.926 \times 0.92). Meanwhile, out of the 994994 healthy patients, a 5%5\% false-positive rate (100%−95%100\% - 95\% specificity) will generate approximately 5050 false positives (994×0.05994 \times 0.05). Because the 5050 false positives vastly outnumber the 55 or 66 true positives, the vast majority of positive test results in this community setting will not actually have the disease (a PPV of roughly 10%10\%).

Adım Adım Çözüm

1
Recall how disease prevalence affects diagnostic testing parameters.
Sensitivity and specificity are intrinsic properties of a test and do not change with prevalence. However, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) are highly dependent on prevalence. As prevalence drops, PPV drops and NPV rises.
Establishing the mathematical relationship between pre-test probability (prevalence) and post-test probability.
2
Calculate the expected number of true positives in a hypothetical community population of 1,000 patients.
With a prevalence of 0.6%0.6\%, there are 66 true disease cases in 1,0001,000 people (1,000×0.0061,000 \times 0.006). With 92%92\% sensitivity, the test correctly identifies 5.525.52 true positives (6×0.926 \times 0.92).
To determine the numerator for the Positive Predictive Value calculation.
3
Calculate the expected number of false positives in the same community population.
There are 994994 healthy individuals (1,000−61,000 - 6). The false-positive rate is 5%5\% (100%−95%100\% - 95\% specificity). The test will produce 49.749.7 false positives (994×0.05994 \times 0.05).
To determine the denominator for the Positive Predictive Value calculation.
4
Evaluate the clinical implication of the calculated values.
Comparing true positives ( 5.5~5.5) to false positives ( 49.7~49.7), the PPV is approximately 10%10\% (5.5/55.25.5 / 55.2). Therefore, nearly 90%90\% of all positive results in this population will be false positives.
To identify the correct statement regarding community deployment from the given options.

Anahtar Kavram

The relationship between disease prevalence and predictive values (PPV and NPV).
ÖncekiSayfa 119 / 237Sonraki